A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy
Clinical trial NCT03416374 · COMPLETED
Trial details
- NCT number
- NCT03416374
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-18
- Primary completion
- 2021-05-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.